Dr Fernanda Schreiber | Postdoctoral Fellow

Schreiber, Fernanda

I am currently working on the development of human intestinal organoids as models for Inflammatory Bowel Disease (IBD). Previously I have worked on host-pathogen interactions, especially looking at the host transcriptome during infection with a range of pathogens, including bacteria and worms.

Publications

  • Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

    Carter GP, Chakravorty A, Pham Nguyen TA, Mileto S, Schreiber F et al.

    mBio 2015;6;3;e00551

  • The Hd, Hj, and Hz66 flagella variants of Salmonella enterica serovar Typhi modify host responses and cellular interactions.

    Schreiber F, Kay S, Frankel G, Clare S, Goulding D et al.

    Scientific reports 2015;5;7947

  • Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling.

    Koh GC, Schreiber MF, Bautista R, Maude RR, Dunachie S et al.

    PloS one 2013;8;1;e54961

  • Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.

    Lawley TD, Clare S, Walker AW, Stares MD, Connor TR et al.

    PLoS pathogens 2012;8;10;e1002995

  • The human transcriptome during nontyphoid Salmonella and HIV coinfection reveals attenuated NFkappaB-mediated inflammation and persistent cell cycle disruption.

    Schreiber F, Lynn DJ, Houston A, Peters J, Mwafulirwa G et al.

    The Journal of infectious diseases 2011;204;8;1237-45

  • Effects of chronic ascariasis and trichuriasis on cytokine production and gene expression in human blood: a cross-sectional study.

    Reina Ortiz M, Schreiber F, Benitez S, Broncano N, Chico ME et al.

    PLoS neglected tropical diseases 2011;5;6;e1157

  • Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

    Carter GP, Chakravorty A, Pham Nguyen TA, Mileto S, Schreiber F et al.

    mBio 2015;6;3;e00551

  • The Hd, Hj, and Hz66 flagella variants of Salmonella enterica serovar Typhi modify host responses and cellular interactions.

    Schreiber F, Kay S, Frankel G, Clare S, Goulding D et al.

    Scientific reports 2015;5;7947

  • Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling.

    Koh GC, Schreiber MF, Bautista R, Maude RR, Dunachie S et al.

    PloS one 2013;8;1;e54961

  • Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.

    Lawley TD, Clare S, Walker AW, Stares MD, Connor TR et al.

    PLoS pathogens 2012;8;10;e1002995

  • The human transcriptome during nontyphoid Salmonella and HIV coinfection reveals attenuated NFkappaB-mediated inflammation and persistent cell cycle disruption.

    Schreiber F, Lynn DJ, Houston A, Peters J, Mwafulirwa G et al.

    The Journal of infectious diseases 2011;204;8;1237-45

  • Effects of chronic ascariasis and trichuriasis on cytokine production and gene expression in human blood: a cross-sectional study.

    Reina Ortiz M, Schreiber F, Benitez S, Broncano N, Chico ME et al.

    PLoS neglected tropical diseases 2011;5;6;e1157

  • Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis.

    Koh GC, Maude RR, Schreiber MF, Limmathurotsakul D, Wiersinga WJ et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52;6;717-25

  • An investigation of clinical and immunological events following repeated aerodigestive tract challenge infections with live Mycobacterium bovis Bacille Calmette Guérin.

    Schreiber F, Huo Z, Giemza R, Woodrow M, Fenner N et al.

    Vaccine 2010;28;33;5427-31

  • High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.

    Goñi F, Prelli F, Schreiber F, Scholtzova H, Chung E et al.

    Neuroscience 2008;153;3;679-86

  • Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma.

    Agorio C, Schreiber F, Sheppard M, Mastroeni P, Fernandez M et al.

    The journal of gene medicine 2007;9;5;416-23

  • Towards new immunotherapies: targeting recombinant cytokines to the immune system using live attenuated Salmonella.

    Rosenkranz CD, Chiara D, Agorio C, Baz A, Pasetti MF et al.

    Vaccine 2003;21;7-8;798-801

Schreiber, Fernanda
Fernanda's Timeline
2014

Postdoctoral Fellow in Host-Microbiota Interactions, Wellcome Trust Sanger Institute, UK

Postdoctoral Fellow in Microbial Pathogenesis, Wellcome Trust Sanger Institute, UK

2011

Postdoc in Cardiovascular Diseases, Department of Medicine, University of Cambridge, UK

PhD in Microbiology, University of Cambridge, UK

2005

MSc in Immunology, Universidad de la Republica, Uruguay

2001

BSc in Biochemistry, Universidad de la Republica, Uruguay